精品国产一区二区桃色

Webinar

Parsing plant pigment pathways

Andrea Lius
June 13, 2025

Flavonoids are plant-derived secondary metabolites that protect plants from pathogens, parasites and abiotic stress, such as extreme weather and temperatures — they essentially act as the plants’ immune system, said , former chair of biochemistry and molecular biology at Michigan State University. Grotewold also serves on the editorial board of the Journal of Biological Chemistry.

Erich Grotewold
Erich Grotewold

“Let’s not forget that plants can’t move when their environments get uncomfortable,” Grotewold said, emphasizing the importance of plant specialized metabolic pathways and products.

Flavonoids are a component of the phenylpropanoid biosynthesis pathway. They were once colloquially known as “” for their antioxidant properties, and their production and sales contribute U.S. dollars every year to the global economy. While not all flavonoids are pigmented, these molecules produce pigments that give flowers their deep, rich colors.

“Flavonoids have contributed (to what) we understand as modern genetics today,” Grotewold said. Indeed, flavonoid studies from the 1980s led to the discovery of the “,” short segments of DNA that can move from one genomic location to another, and , which is now a common tool in research and biotechnology.

Grotewold was this month’s speaker on ASBMB Breakthroughs, a webinar series highlighting research from 精品国产一区二区桃色 journals. During his talk, sponsored by JBC, he shared his discovery that flavonoid gene regulation is controlled by the interaction between transcription factors, rather than their DNA-binding specificity.

“My journey into plants started by trying to figure out how (the two branches of the flavonoid biosynthesis pathway), which involve the same DNA-binding domain and in some regards, very similar compounds, are differentially regulated,” said Grotewold.

Some flavonoids produce pigments that give flowers and fruits their colors.
Some flavonoids produce pigments that give flowers and fruits their colors.

In corn, the flavonoid biosynthesis pathway forks into two branches: one forms phlobaphenes, a pigment that is unique to grass plants, and the other, anthocyanins, which are more widely distributed throughout the plant kingdom. These branches are regulated by the transcription factors P1 and C1, respectively. However, Grotewold explained, both P1 and C1 contain the same DNA-binding domain, known as MYB, and thus have very similar DNA-binding specificities.

Genes in the anthocyanin biosynthesis pathway are regulated by the physical interaction between the MYB domain on C1 and another transcription factor called R. Grotewold that six amino acids on C1, four of which are on the solvent-exposed surface of MYB, confer C1’s specificity for R. When Grotewold substituted the amino acids at these positions on P1 for those found on C1, the modified P1 protein gained the ability to interact with R and activate the anthocyanin pathway.

Grotewold and his colleagues that R can act as a “regulatory switch” — the configuration of one of R’s domains, called ACT, can determine whether it interacts with MYB, and subsequently, which genes are being targeted and which pathways activated. This indicated that gene regulation in flavonoid biosynthesis depends on the interaction between transcription factors, not DNA binding specificity, Grotewold said.

“We now know that this six amino acid motif that we initially found in C1 regulates a lot of different processes in plants, even beyond the formation of anthocyanin pigment (the pathway’s end-product in corn),” he added.

More recently, Grotewold’s team has been studying flavonoid biosynthesis in Arabidopsis thaliana, a small flowering plant in the mustard family. They found that naringenin chalcone, one of the pathway intermediates, can interact with and stabilize ultraviolet-B receptor protein, or UVR8, in a UV-independent manner. Grotewold said that he found this surprising not only because UV-independent functions of UVR8 were previously unknown, but also because it suggested that naringenin chalcone may be more important than once expected.

“We typically ignore pathway intermediates because we think of them as biologically inactive,” Grotewold said, “But we saw that they can have very important regulatory activities.”

Up next

Ileana Cristea

TBD

June 18, 2025  12:15–1 p.m. Eastern
Ileana Cristea of Princeton University will present her research on using mass spectrometry to study viruses.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Andrea Lius

Andrea Lius is a Ph.D. candidate in the Ong quantitative biology lab at the University of Washington. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.